Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer

NCT00003892 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.

NCT NCT00003892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer
Lead sponsor
NCIC Clinical Trials Group
Phase
Phase 2
Overall status
Completed
Start date
February 1, 1999
Completion date
September 22, 2008
Enrollment
22 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer